Humana (HUM) Non Operating Interest Expenses (2009 - 2026)

Humana (HUM) has reported Non Operating Interest Expenses for 18 consecutive years, with $197.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 25.48% year-over-year to $197.0 million in Q2 2026; TTM through Jun 2026 was $704.0 million, a 8.31% increase from a year earlier, with the FY2025 full-year figure at $631.0 million, down 4.39% from the prior year.
• Non Operating Interest Expenses was $197.0 million for Q2 2026 at Humana, up from $193.0 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $197.0 million in Q2 2026 and troughed at $90.0 million in Q1 2022.
• A 5-year average of $143.1 million and a median of $151.5 million in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 48.25% in 2024 and declined 10.98% in 2025, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $108.0 million in 2022, then jumped by 35.19% to $146.0 million in 2023, then climbed by 12.33% to $164.0 million in 2024, then slipped by 10.98% to $146.0 million in 2025, then jumped by 34.93% to $197.0 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $197.0 million (Q2 2026), $193.0 million (Q1 2026), and $146.0 million (Q4 2025), per Business Quant data.